Steroid sulfatase (STS) deficiency is the underlying cause of the skin condition known as recessive X-linked ichthyosis (RXLI). RXLI patients show scales on their skin caused by high concentrations of cholesterol sulfate (CS), as they are not capable of releasing the sulfate group from its structure to obtain free cholesterol. CS has been reported so far as the sole sulfated steroid with increased concentrations in the blood of RXLI patients. A non-targeted liquid chromatography-mass spectrometry approach in negative mode detection (LC-MS precursor ion scan mode) was applied to serum samples of 12 RXLI patients and 19 healthy males. We found that CS was not the only Other hydroxycholesterol sulfate compounds were elevated as well in RXLI patients.
INTRODUCTION
Steroids play critical physiological roles in a wide number of organisms, including animals, plants and fungi. In humans, most of the steroids present in blood and in urine are conjugated steroids rather than free forms. This conjugation is mainly due to the addition of a sulfate or glucuronide group. An example is the high concentration of dehydroepiandrosterone sulfate (DHEAS) in blood when compared with its unconjugated form, DHEA. The addition of a very polar group to the structure of steroids increases their solubility in water and facilitates their urinary excretion.
Moreover, the physiological activity of some steroidal hormones is blocked by this sulfation mechanism. Therefore, action of steroid sulfatase (STS) processes active free steroids.
For decades, sulfated steroids have been regarded as inactive precursors only. More recently, new roles have been assigned to some of these molecules. For instance, pregnenolone sulfate (PregS) and DHEAS have been found to be neuroactive compounds (1) . Furthermore, a specific membrane by guest, on www.jlr.org Downloaded from 4 CS is one of the most abundant steroid sulfates found in blood of healthy persons (14) . Different physiological roles have been ascribed to CS, including membrane stabilization, support of platelet adhesion or regulation of serine proteases (14) . It has been shown that elevated CS levels inhibit serine proteases and thus inhibit normal desquamation, resulting in a retention hyperkeratosis (15) .
CS analysis is challenging and it has been mostly carried out using gas chromatography-mass spectrometry (9, 10, 16, 17, 18) . The amphipathic character of this relatively simple molecule, which is due to the conjugation of the lipophilic cholesterol with the sulfate polar group, makes it particularly susceptible to suffer from matrix effects in LC-MS (19) . To the best of our knowledge, only two papers have been published making use of LC-MS to quantify CS in blood (19, 20) . Only one study focused on the CS concentration in patients with RXLI (20) .
So far, no research has been conducted to study in detail if other compounds different than CS are increased in RXLI. This is of importance because it has been hypothesized that an additional steroid sulfatase activity is present in humans complementing the activity of STS (8) . In this context, LC-MS/MS is the technique of choice as it offers powerful tools to study the human sulfated steroidome. The sulfated steroids can be analyzed as intact molecules (21) without any need for derivatization, providing important structural information, e.g. position of the sulfate in the structure. Of note, sulfated steroids have very specific transitions in tandem mass spectrometry experiments (21, 22, 23) .
For this study we collected serum samples from 12 patients with a clinically and enzymatically confirmed diagnosis of RXLI and made use of LC-MS/MS to search for differences in the sulfated steroidome. By means of non-targeted mass spectrometry tools, the comparison of serum from 5 hydroxycholesterol, better named as (25R)-26-hydroxycholesterol (24) and 7α-hydroxycholesterol.
The latest ones are the starting molecules for the acidic and neutral pathways for bile acid synthesis, respectively.
Some of the most relevant monosulfated and disulfated hydroxysterols have been previously identified, synthesized and characterized (25, 26, 27, 28) . Among these, 25-hydroxycholesterol-3-sulfate (25OHC-3S) has been studied with more detail, and its physiological activities and regulatory capacities have been described (28) .
Our findings will help to understand the characteristics of the STS-independent steroid sulfatase activity in humans. A sample from a patient with cholestasis was compared with the profiles obtained in RXLI patients, showing remarkable differences. Finally, an assay for the determination of 27OHC3S has been developed and validated. This method can facilitate the diagnosis of RXLI.
MATERIALS AND METHODS

Study design and selection of patients
The study being part of the Network for Ichthyosis and Related Keratinization disorders (NIRK) was approved by the institutional review board of the University Hospital of Münster (2013-573-f-S). Written informed consent was obtained by all study participants. A detailed medical and dermatological history was obtained from all affected persons. Clinical diagnosis was made by experienced dermatologist (V.O. and H.T.). Serum blood was collected for STS activity testing.
Punch biopsies (4 mm) for histology or ultrastructure were taken in some patients. 
Materials
Experimental procedures for the identification of the steroids elevated in RXLI patients
Sample preparation for isolation and identification of sulfated steroids
Sample workup was designed to permit effective isolation of sulfated steroids from free steroids.
The method required 250 μl of serum. Protein content was precipitated with 1 ml of acetonitrileZnSO4 (89 g/l) 4:1 (v/v). The supernatant obtained after centrifugation of the samples was taken into a glass tube and then mixed with 3 ml of water. The mixture was then transferred to a Seppak C18 cartridge which was conditioned with 2 ml of MeOH and 2 ml of water. Once the sample was loaded onto the cartridge, it was washed in four steps: 3 ml of water first, followed by 3 ml of hexane, 4 ml of chloroform and finally 4 ml of MeOH. The methanolic fraction containing the sulfated steroids was then evaporated under a flow of nitrogen heating the samples at 40 °C and redissolved in a specific solution according to the final purpose of the analysis. and then a gradient is applied to return to initial conditions.
The mass spectrometer was operated first in negative parent ion scan mode (precursor ion scan mode) with a product mass of 96.9, a scan range of m/z 30-650, a scan time of 1 second and collision energy of 45V. The same parameters were applied to a product mass of 79.9. Product masses were selected in accordance with different studies which showed this is the most common fragmentation product, with exception of estrogen sulfates (21, 22, 23) .
Confirmatory experiments were performed thereafter, with the specific transitions from compounds which were increased or only found in RXLI samples after dilution. The mass spectrometer was operated in multiple reaction monitoring mode (MRM) with two transitions for each parent mass:
96.9 and 80 (Collision energy 45 eV, Tube Lenses 100 V).
MS conditions were always as already published for the analysis of sulfated steroids (21) .
Characterization of sulfated steroids with increased concentrations in RXLI
After sample preparation of RXLI serum samples, methanolic extracts were solvolyzed. 50 μl of the 
Sample preparation for analysis of intact oxysterol sulfates
Sample workup was as described in the section "Sample preparation for isolation and identification of sulfated steroids". For each serum sample, 15 μl of d627OHC3S, the internal standard (IS) of 27OHC3S, were mixed with 250 μl of serum to a final concentration of 12 ng/ml. After 1 hour equilibration under continuous shaking, protein content was precipitated following the aforementioned protocol. After evaporation of the methanolic fraction at 40 °C, samples were reconstituted in a 250 μl solution containing 54.75% water 45 % acetonitrile and 0.25% ammonium hydroxide. If needed, the solution was diluted two times for quantification of 27OHC3S in RXLI samples. Centrifugation was applied to those samples which were not clean after reconstitution, analyzing the supernatant.
Mass spectrometry and liquid chromatography for analysis of intact oxysterol sulfates
Mass spectrometry analyses of sulfated compounds were performed on a triple quadrupole mass spectrometer with negative electrospray ionization (TSQ, Quantum Ultra, Thermo Fisher Scientific, Dreieich, Germany). Mass spectrometer conditions were as described before for sulfated steroids 
Method validation
Several experiments were performed to validate the method for the determination of 27OHC3S in human serum. Charcoal-treated serum was chosen for method validation. Real serum from a pool of healthy patients with no detectable amounts of 27OHC3S was used as well, in order to study possible differences. Charcoal-treated serum was preferred as it is free of other sulfated oxysterols, which may interfere with the analysis.
Linearity, calibration, detection limit and quantification limit
The area ratio of 27OHC3S to d627OHC3S was plotted against the specific concentration in nanograms per milliliter. Linearity data were calculated using the program Xcalibur 2. The final concentration for IS was 12 ng/ml. The limits of detection (LOD) and the limits of quantification (LOQ) were determined at signal-to-noise (S/N) ratio higher than 3 and higher than 10, respectively.
Selection of quality control concentration levels
Based on preliminary results, two quality controls were chosen to study the validation process: 5 ng/ml (Low Quality Control, LQC) and 50 ng/ml (High Quality Control, HQC). These were prepared by spiking the standards to charcoal-treated serum.
Recovery
The recovery of the method, which evaluates the effect on analyte loss by C18 cartridges, was calculated by dividing the area ratios for the quality controls (with addition of 27OHC3S and IS pre-extraction to charcoal-treated serum, incubation, precipitation and solid phase extraction, evaporation of the methanolic extract and reconstitution) by the area ratio obtained after spiking the same amounts of the analyte and IS post-extraction (spiked onto a methanolic extract from charcoal-treated serum which was then evaporated and reconstituted).
Matrix effects
The evaluation of possible matrix effects associated to the method was performed by plotting response ratios of controls spiked in charcoal-treated serum after sample workup (Y-axis) against the same concentrations of analyte and IS in the reconstitution solution (X-axis). The same experiment was repeated with a serum pool with no signal for 27OHC3S instead of charcoal-treated 
Carryover
Carryover was studied by injecting blank samples (ACN:water 1/1) after injection of a 27OHC3S
calibration sample with a concentration of 500 ng/ml.
Intra-assay and inter-assay precision and accuracy
Each quality control was injected four times during the same day to calculate intra-assay precision and accuracy. Analysis of the quality controls injected three times each day during three consecutive days were used for the determination of inter-assay precision and accuracy.
Analysis of samples
12 serum samples from RXLI male patients of different ages, previously diagnosed by genetic analysis, were studied and compared with 19 samples from healthy males of different ages. A sample from a baby (3.5 months) diagnosed of cholestasis was studied too.
RESULTS
Synthesis of sulfated standards and sulfonation of d627OHC
The method described rendered a higher yield of 27OHC3S than the sulfated 27OHC in position 27 (27OHC27S) or the disulfate. HPLC separation was needed to isolate the compound. In a similar way, sulfonation of the deuterated compound d627OH produced three peaks; disulfated 27OHC and the monosulfates 27OHC27S and 27OHC3S.
The identification of the retention times for each monosulfate was achieved by studying the specific fragmentation patterns of the sulfonation products obtained from d627OH. Two deuterium atoms 
Sample workup
Sample preparation was implemented for specific isolation of the sulfated steroids from their unconjugated forms. Consequently, sulfated steroids, as well as steroid glucuronides and some bile acids, were isolated on the last step of the sample preparation (methanolic extract), whereas unconjugated steroids were collected in the chloroform fraction.
Non-targeted approach results
Two signals were consistently increased with independence of the age of the patient. These were m/z 465.2 from CS and m/z 481.2 coming from oxysterol sulfates (figure 2).
Chromatography
Acetonitrile was chosen as it allowed for a better separation of oxysterol sulfates when compared A sample from a baby diagnosed with cholestasis was prepared as well. The main peak found in RXLI patients was due to 27OHC3S, whereas one of the most abundant peaks in the cholestasis sample profile was 27OHC27S.
Controls
The addition of high concentrations of CS or d7CS did not produce oxysterol sulfates, as they could not be detected by LC-MS/MS.
Validation
Results for validation process of the 27OHC3S determination assay are shown in table 2.
Sample analysis
All RXLI samples showed a similar profile for the transition m/z 481→97 in our LC method for the analysis of intact sulfated steroids. The main peak found is due to 27OHC3S, as it coelutes with d627OHC3S and has the same retention time as the synthesized standard. concentrations of 27OHC27S (co-elution with d627OHC27S) and of other sulfates present in RXLI (mostly 24OHC sulfates), as can be seen in fig. 3B . The signal for 27OHC3S in samples from healthy volunteers was not measurable, as its concentration was below the LOQ. A peak which might be due to 25OHC-3S or 24OHC sulfates was present ( fig. 3D) 
DISCUSSION
Method development
The goal of this work was to discover if any other sulfated steroid, different from CS, was elevated in serum of patients suffering from RXLI independent of age. Several approaches were needed to identify and quantify those compounds. A decisive step was to perform solvolysis of the serum extract under room or lower temperatures than usual, as it was verified that at higher temperatures some oxidized species of CS were formed (data not shown). Therefore, controls were essential in this case. Another important aspect was the separation of the sulfated fraction from the different unconjugated forms of steroids, in order to avoid matrix effects. Our final sample preparation protocol shares similarities with the one published by Raeside et al. (31) , in which their aim is to separate free and steroid sulfates. Likewise, the sample workup reported by Fong et al. for CS is based in an equivalent principle (19) .
The LC-MS/MS method presented here is, to our knowledge, the first one which permits the direct analysis of 27OHC3S in serum samples. Previously, Javitt et al. studied the capacity of some sulfotransferases to produce sulfated oxysterols by HPLC (25) . In this first attempt, intact monosulfates of 27OHC could not be resolved by LC. Our method achieves baseline separation of 27OHC3S and 27OHC27S, allowing for identification of the two related isobaric compounds in a single run time of 7.5 minutes. Gas chromatography can not provide such information, since after cleavage of the sulfate(s) group(s) from the intact compound for derivatization, the resulting molecule is always 27OHC.
With our method, and after dilution of RXLI samples, 27OHC3S can be easily separated from other isobaric molecules, too (25OHC and 24OHC sulfates). For example, our method also enabled the identification of the specific compounds present in the serum sample from a cholestatic baby. Our patient with cholestasis showed a different pattern of oxysterol sulfates
Most important, this assay represents a novel laboratory tool for the specific diagnosis and confirmation of RXLI.
Measurements in cholestasis,
Recent research reported an elevation of 24OHC and 27OHC sulfates in cholestatic patients (32) , but the method used in this work could not specify which positions were sulfated. The authors faced reproducibility problems using sulfatase from Helix pomatia H1. Therefore, solvolysis was chosen, so sulfated positions in the oxysterols could not be studied. Other publications studying cholestasis made use of GC-MS analysis too, and solvolysis was used again to cleave the sulfate from their structure (33, 34) .
In the sample from our cholestatic patient, 27OHC3S is present. Quantification was not possible due to the presence of higher concentrations of other sulfated steroids. In this sample, 27OHC27S
was significantly elevated in comparison to 27OHC3S. showed a much lower mean CS concentration of 2.6 ±0.6 μmol/L.
We found that CS is not the only sulfated steroid elevated in RXLI since other compounds, oxysterol sulfates, were confirmed to be elevated in RXLI, too. This was independent of the age of the patients. We proved that hydroxysterol sulfates are not a consequence of sample handling or sample preparation, and therefore their origin is more likely enzymatic. There are two main probable routes by which oxysterol sulfates might be formed. Once the oxysterols are synthesized from cholesterol, they can undergo sulfonation by a sulfotransferase (25) . But additionally, they could be enzymatically produced from CS, as was described by Norlin et al. in 2003 . In their studies, they found that in vitro, CS is a better substrate for CYP27A1 than cholesterol itself (35) .
Cook et al. discovered that human STS can cleave the sulfate in position 3 of 24OHC3S, but not the sulfate in position 24 (26). Therefore, it is probable that the increased levels of 24OHC3S associated to RXLI are due to the lack of STS activity, and the impossibility of cleaving the sulfate group from 24OHC. A similar mechanism could contribute for the high concentrations of the rest of hydroxycholesterol sulfates, including 27OHC3S, but no experiments have been done so far to clarify if human STS can desulfate 27OHC3S.
Sulfatase activity in RXLI
The experiments and controls performed in this work proved that all the samples from patients with STS deficiency presented high levels of oxysterol sulfates, particularly 27OHC3S.
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The presence of these compounds is independent of the age of the patient. Previous studies found that CS is around 30 times higher in RXLI than in healthy people (20) . If STS was the sole factor responsible for sulfatase activity in humans, then the rest of sulfated steroids (i.e. DHEAS) should be grossly elevated as CS and 27OHC3S are. Delfino et al. studied the concentration of DHEAS in RXLI related to the age of the patient (16). They found DHEAS was increased about 1.8 times in RXLI with respect to controls whereas CS was about 12.7 times higher. Therefore, there must be more than one steroid sulfatase activity in healthy humans.
Human STS can desulfate CS. On the contrary, the additional steroid sulfatase activity (different than STS), which is the only steroid sulfatase acting in RXLI, seems unable of cleaving the sulfate from CS, 27OHC3S or any other sulfated steroids with 27 carbons.
As explained in the introduction, some authors proposed gut microorganisms could be responsible for this auxiliary mechanism. Sulfated steroids would reach the gut flora through enterohepatic circulation (13). This mechanism seems quite possible because it has been proved that the ingestion of antibiotics increases the concentration of sulfated steroids in feces (36, 37) .
During our experimental work, different approaches were used to try to release the sulfate from the structure of the steroids with 27 carbons. The use of a commercial sulfatase, obtained from Helix pomatia H1, did not provide reproducible data, in consonance with Acimovic et al. (32) . CS can not be desulfated in a reproducible way either (38) .
Similarly, some human bacterial sulfatase enzymes are unable of desulfating certain steroids which can be desulfated by human STS, including CS (39) . Peptococcus niger H4 is an example of a human gut bacterium isolated from feces with steroid sulfatase activity, which fails to desulfate CS (40) . The enzymatic substrate specificity of the sulfatases studied in Peptococcus niger H4 matches with the results found in this work and in previous ones studying RXLI.
Assuming a gut microorganism is partially responsible for the steroid sulfatase activity in humans, a disruption in this activity would have a stronger effect in RXLI patients than in healthy ones, as a healthy person has two different sources of steroid sulfatase activity. Some sulfated steroids have been shown to be neuroactive molecules (DHEAS, PregS), and therefore a modification on the balance of sulfated steroids in RXLI early childhood could affect their neuronal development.
Following this hypothesis, a prolonged lack of total steroid sulfatase activity in children with RXLI (lack of gut bacterial steroid sulfatase activity) would elevate the levels of all their sulfated steroids.
This more pronounced vulnerability could be the reason for the high percentage of RXLI patients suffering of neurodevelopmental disorders, since about 20% of them develop autistic spectrum disorders and 40% have attention-deficit hyperactivity syndrome.
In consequence with the findings described in this work, further research should be done to find out if there is a correlation between sudden alterations on the sulfated steroids concentrations and the development of some neurodevelopmental disorders in children. Additionally, the effects of the continuous presence of high concentrations of certain hydroxycholesterol sulfates, which have been proved to have regulatory capacities in some cases (26, 28), should be studied in detail. 
